NYSEAMERICAN:INFU

InfuSystem (INFU) Stock Price, News & Analysis

$7.74
-0.46 (-5.61%)
(As of 04/22/2024 ET)
Today's Range
$7.70
$8.38
50-Day Range
N/A
52-Week Range
$7.70
$11.44
Volume
46,973 shs
Average Volume
45,133 shs
Market Capitalization
$164.55 million
P/E Ratio
258.09
Dividend Yield
N/A
Price Target
N/A
INFU stock logo

About InfuSystem Stock (NYSEAMERICAN:INFU)

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

INFU Stock Price History

INFU Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
InfuSystem Holdings Inc
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Q4 2023 InfuSystem Holdings Inc Earnings Call
InfuSystem Holdings: 2024 Will Be A Year Of Monetization
Analysts’ Top Healthcare Picks: EDAP TMS (EDAP), DermTech (DMTK)
InfuSystem Q3 2023 Earnings Preview
See More Headlines
Receive INFU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
4/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:INFU
Employees
499
Year Founded
N/A

Profitability

Net Income
$870,000.00
Pretax Margin
1.47%

Debt

Sales & Book Value

Annual Sales
$125.79 million
Cash Flow
$0.60 per share
Book Value
$2.47 per share

Miscellaneous

Free Float
17,331,000
Market Cap
$164.55 million
Optionable
Not Optionable
Beta
1.24
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Richard A. DiIorio (Age 49)
    CEO & Director
    Comp: $1.14M
  • Ms. Carrie A. Lachance B.S.N. (Age 47)
    M.B.A., R.N., President, COO & Director
    Comp: $831.31k
  • Mr. Barry G. Steele (Age 53)
    Executive VP & CFO
    Comp: $725.43k
  • Mr. Addam Chupa (Age 45)
    Executive VP & Chief Information Officer
  • Mr. Jerod Funke (Age 49)
    Executive VP & Chief HR Officer
  • Jeanie Latz
    Corporate Secretary

INFU Stock Analysis - Frequently Asked Questions

Are investors shorting InfuSystem?

InfuSystem saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 233,700 shares, a drop of 11.1% from the March 15th total of 262,900 shares. Based on an average trading volume of 46,200 shares, the short-interest ratio is currently 5.1 days. Approximately 1.3% of the shares of the stock are sold short.
View InfuSystem's Short Interest
.

How were InfuSystem's earnings last quarter?

InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) released its quarterly earnings results on Monday, November, 15th. The medical instruments supplier reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of $0.03 by $0.05. The medical instruments supplier earned $26.57 million during the quarter, compared to the consensus estimate of $28 million. InfuSystem had a net margin of 0.69% and a trailing twelve-month return on equity of 1.73%.

What other stocks do shareholders of InfuSystem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Second Sight Medical Products (EYES), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS).

How do I buy shares of InfuSystem?

Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:INFU) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners